Approved for Treatment of IBS-C in women under 65 without cardiovascular risk factors. Stimulates serotonin 5-HT4 receptors in the GI tract, increasing motility and reducing visceral sensitivity. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.
Loading full data from Know Your Drugs Institute…